CAMPBELLVILLE, ON, June 20 /CNW/ - NIR Diagnostics Inc. (TSX Venture: NID - News), a leading-edge developer of handheld spectroscopy based medical instruments, announced today that it has entered into a definitive license and royalty agreement with Shaklee Corporation, a nutrition, skin care, and household products company, to develop, manufacture, distribute and market NIR Diagnostics’ in-vivo light-based technology and the HemoNIR(TM) CO-oximeter device. The agreement requires shareholder and regulatory approval and is subject to customary conditions, including time limited mutual confirmatory due diligence regarding selected aspects of the transaction.
